Kezhou Xia

238 Jiefang Road
Wuhan, 430060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

IRF2BPL inhibits proliferation, migration and invasion of osteosarcoma cells by inhibiting FOSL2-mediated PI3K/AKT pathway activation.

IRF2BPL inhibits proliferation, migration and invasion of osteosarcoma cells by inhibiting FOSL2-mediated PI3K/AKT pathway activation.

Journal: Cellular signalling

Published: May 07, 2025

RNF207 promotes the proliferation, migration and invasion of osteosarcoma through KCNQ1 mediated activation of ERK/MEK signaling pathway.

RNF207 promotes the proliferation, migration and invasion of osteosarcoma through KCNQ1 mediated activation of ERK/MEK signaling pathway.

Journal: International immunopharmacology

Published: April 21, 2025

HMGCL activates autophagy in osteosarcoma through β-HB mediated inhibition of the PI3K/AKT/mTOR signaling pathway.

HMGCL activates autophagy in osteosarcoma through β-HB mediated inhibition of the PI3K/AKT/mTOR signaling pathway.

Journal: Journal of translational medicine

Published: November 14, 2024

SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K/AKT/mTOR signaling in osteosarcoma.

SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K/AKT/mTOR signaling in osteosarcoma.

Journal: Journal of translational medicine

Published: August 23, 2024

CGREF1 modulates osteosarcoma proliferation by regulating the cell cycle through the Wnt/β-catenin signaling pathway.

CGREF1 modulates osteosarcoma proliferation by regulating the cell cycle through the Wnt/β-catenin signaling pathway.

Journal: Molecular medicine (Cambridge, Mass.)

Published: August 18, 2024

DUSP3 restrains the progression and stemness property of osteosarcoma through regulating EGFR/STAT3/SOX2 axis.

DUSP3 restrains the progression and stemness property of osteosarcoma through regulating EGFR/STAT3/SOX2 axis.

Journal: International journal of biological sciences

Published: July 18, 2024

The homeobox family gene signature predicts the prognosis of osteosarcoma and correlates with immune invasion.

The homeobox family gene signature predicts the prognosis of osteosarcoma and correlates with immune invasion.

Journal: Scientific reports

Published: April 10, 2024

Nanofiber-induced hierarchically-porous magnesium phosphate bone cements accelerate bone regeneration by inhibiting Notch signaling.

Nanofiber-induced hierarchically-porous magnesium phosphate bone cements accelerate bone regeneration by inhibiting Notch signaling.

Journal: Bioactive materials

Published: December 24, 2023

SERPINH1 enhances the malignancy of osteosarcoma via PI3K-Akt signaling pathway.

SERPINH1 enhances the malignancy of osteosarcoma via PI3K-Akt signaling pathway.

Journal: Translational oncology

Published: July 07, 2023

Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma.

Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma.

Journal: BMC cancer

Published: June 28, 2023

Zyxin Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma via Rap1-Mediated Inhibition of the MEK/ERK Signaling Pathway.

Zyxin Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma via Rap1-Mediated Inhibition of the MEK/ERK Signaling Pathway.

Journal: Biomedicines

Published: June 26, 2023

RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway.

RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway.

Journal: Molecular medicine (Cambridge, Mass.)

Published: May 22, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026